Tort Reform Likely To Move Up PhRMA Priority List
The continued fallout from the Vioxx withdrawal is likely to make tort reform a higher priority for the Pharmaceutical Research & Manufacturers of America heading into 2005
The continued fallout from the Vioxx withdrawal is likely to make tort reform a higher priority for the Pharmaceutical Research & Manufacturers of America heading into 2005